annual pharmaceutical statistical report -...

Annual Pharmaceutical Statistical Report

2006-2007

2

.

,

.

.

.

3

.

.

.

.

.

.

4

.

-

- -

com.hotmail@Statistic_GDOP

.

6

List of Acronyms NGO :

7

List of Tables Table 1:

8

List of Figures Figure 1:

9

.

,

,

.

2007-2006

, .

.

( )

.

.

.

.

11

: )1(

) 2.5(

18.5 21.75 23 3.5

.

.

.

. ) (

.

: ) 2 (

) 25.6( 1993

) 11.5( ) 37.8( %) 2.53( ) 37239 (2007

: 2005

% 37.56 % 44.69 ) 24 6( % 41.25 15 % 15.23 % 4.0 60 % 85 % 15

.

2004 % 34.8 1993 % 29

.

12

Figure No -1- Map of Sudan

Main Health Indicators 2004 Item

Value

Year Source

/ 1Demographic and Socioeconomic indicators

Demographic indicators

Area 2.506.000.km Census 1993 1993 Population (Millions) 25.6 1993 ) 000) ( ( ( Population Projection 2004(Millions) 34.5 2004 2004

)Population Data Sheet (CBS- UNFPA)

Census 1993 1993 Crude birth rate ( per 1000 pop. ) 37.8 98-2003 ) 1000 ( Census 1993 1993 Crude death rate ( per 1000 pop. ) 11.5 98-2003 ) 1000 (

Census 1993 1993 Annual growth rate ( % ) 2.53 2004 ( Natural Increase Rate 1000 26.3 98-2003

)Population Data Sheet (CBS- UNFPA)

( Pop Under 15 Years % 41.8 2004 15 )

Population Data Sheet (CBS- UNFPA)

( Pop over 65 years % 4.0 2004 65 )


( Total Fertility Rate % 5.9 1999 )


( Urban population % 36.8 2004 )


2/ Socioeconomic data

50.6 M 49.2 F

15

Adult literacy rate 15+

49.9 T

MICS 2000 2000

Economically active population , 10 yrs ) 10 ( and over %

Census 1993 1993 1993 32.1

Census 1993 1993 Dependency rate / 1000 87 1993 1000 Census 1993 1993 Per capita GNP ( US $ ) 330.0 1993

Sudan in figures Per capita GDP ( US $ ) 570 1990 / 3

Health expenditure

Per capita ( US $ ) of :- GDP 578 2004 FMOH P/HE

14

Annual Federal expenditure per capita in US$

FMOH P/HE 2004 2.1

Item Value

Year

Source

/ 3Health activities

pop. For whom health care is available 70.0 1992 %

PAPCHILD

(MICS (NORTH of pop. With safe drinking water 59.8 2000 %

% of pop. Adequate excreta disposal facilities 59.7 2000 MICS (NORTH)

% of pregnant women attended by trained personnel

(MICS (NORTH 2000 71

of women delivered by trained personnel 57 2000 % of infant attended by trained personnel 30 1992 %

PAPCHILD

of pregnant women given tetanus toxoid ( 2 % doses + )

37 2004 EPI / FMOH

DPT 79 2004

OBV 79 2004

Measles 72 2004

B C G 71 2004

-: / 5 ) (

Health status :- (a)Morbidity

2500

% of newborns with birth weight at least 2500g 69 2000 MICS (NORTH)

of children with acceptable weight for age 67 1991 % /

WHO

- :) ( (b)Mortality

Under 5 mortality rate (1000 live births) 104 1999 ) 1000( 5 1999

SMS 1999( NORTH )

) 100000(

Maternal mortality / 100.000 live birth 509 2000 S.M.S.

Live expectancy at birth ( yrs ) M 52 F 5.5

Census 1993 1993 1993

15

B 54

:

.

.

.

2000 360 2007 1251

.

) (2005-2004(

(GDP) % 0.56 2005 2004

.% )2( .2007 0.31%

. 1 3.8

( ) (

29 11 7.5 )

34 out of pocket expenditure)(

.

.

.

.

1

17

2007-2000

2007 2005 2004 2000

,11,038,337 3,521,601,000 000

14,510,000,000

20,971,000,000

294,701,371 295,870,000 185,517,000 73,187,000

28,455.2 71,352.9 116,027.5 147,350.7

4 3.3 2.1 0.9

8 8 5 2

2.08 1.68 2.20 1.4

,51,680,000 28,770,000,000 000

55,310,000,000

92,800,000,000

.19,876,923 11,185,847.6 0

20,777,000.0 46,400,000.0

360 578 589 1,251

GDP

0.25% %0.36 %0.56 0.31%

2007-2000

0.1

1

10

100

1000

10000

1 2 3 4

- -

18

2006

Saudi

Arabia Jordon Egypt Sudan

Indicator NO

13,365 2,293 1,290 756 GDP per capita 1

448 241 78 29 Total expenditure on health (per capita) 2

341 109 30 11 General government expenditure on health (per capita)

3

3.4 10.5 6.1 3.8 Total expenditure on health of % of GDP 4

76.2 45.3 38.0 37.6 General government expenditure on health as % of total health expenditure

5

3.9 41.6 58.8 61.4 Out-of-pocket expenditure as % of total health expenditure

6

5.6 5.6 3.4 2.0 General government expenditure on health as % of total general government

expenditure

7

8.7 9.5 7.3 7.0 Ministry of health budget as % of government budget

8

0500

100015002000250030003500

19

02468

1012

0500100015002000250030003500

2005

) (

137.5

0.6%

60%

40%

26.8

0.7%

26%

74%

8

0.9%

33%

67%

7

0.07%

6%

76%

). % 76 ( % 75

, 2005 % 27.6 % 28

. % 18

20

. 0.4 2005

1

. % 60

Household Expenditure Out Of Pocket Expenditure

.

% 70

.

) + (

%5 %93

%17 %62

%10 %90

22

.

.

.

.

.

2007 2002

.

.

.

) (

) (

.

4 19

.

.

% 91

% 42

.

23

%. 0 % 92

) (

. %91 %92

.

.

. 21 862

7.133.868

. % 29.4 . % 30

.

.

.

20

74

.

) ( 2007

% )67 ( % . 83

. % 58

.

24

0

10

20

30

40

50

60

70

80

2001 2002 2003 2004 2005 2006 2007 2008

19

7

25

2005

100

25

25

1

2 51 48 94

3 18 18 100

94

16

17

4

100

26

26

5

+

6 10 9 90

7 23 23 100 % 95.6 % 80

% 20+

8 20 20 100

% 67+ % 30 %3+

9 9 9 100

10 20 20 100

% 64 % 36+

11 . 21 21 100

12 .

13 . 13 13 100

26

2005

+

14 .

+

15 . 4 4 100

27

%

%

%

%

%

1 144 144 100 % 29

%71 + 2 189 153 81

%27 %+73

3 31 31 100

4 41 41 100 5 63 63 100

+

6 60 53 88

7 98 98 100 % 50

% 20+ % 30+ 8 51 51 100

9 20 20 100 10 28 28 100

% 22 % 64+

11 . 45 38 84

12 . 13 . 12 12 100 + +

+ 14 . 10 2 20

15 . 10 4 40 +

28

2005

2005 2001 ,1993, 1987 1981

.

2009 -2005

.

%30. 951 565

.

.

% 3

% 40

% 34

% 23

29

. % 13 % 38

252 211

. 77 68 . 2005

. % 27

. 2005 116 87

. 663 338

% 34

. % 85

2005 ( )

2005

2005

51% 36%

75% 9%

83% 27 %

88% 8%

85% 34%

33

....

.

34

.

. 7000

.

.

. ,

( )

.

2007 2002 2002

. 5872 2007

350

100

200

300

400

500

600

700

800

2002 2003 2004 2005 2006 2007

2007-2002

%82 )2007 2002( .

2002 . % 12

. 1968

% 32

2007- 2005

.

) ( .

. 1300 2009 .

0200400600800

100012001400

1968-1969 1978-1979 1988-1989 1998-1999 2008-2009

36

2007-2002

0 10 20 30 40 50 60 70

2002

2003

2004

2005

2006

2007

2007-2002

0

20

40

60

80

100

120

2003 2004 2005 2006 2007

37

0

10

20

30

40

50

60

70

80

100

00

Admission/pharmacist ratio.

2008

. 13 78 14000

.

12

5200

38

2006

0.00 0.50 1.00 1.50 2.00 2.50

).2006( 1650 . 2007

13000 24

. 1500

.

.

157 2006

.

- :

2007 5872 90

) (

.

2005

. 199

.

39

2005

%2

%98

.

. . % 17

.

.

)2013 2004(

1

2431

843

1588

40

%66

%34

( )

%56

%44

2

410

32

378

3

4882

759

4123

4

1634 7723

21%

).On Job Training(

.

.

% 45

% 51 . ) (

) . (

41

77%

% 33

)2007 (

2007 2003

9573 5949 * 1

512 244 * 2

1542 674 * 3

42

2007

0

20

40

60

80

100

120

.

.

.

.

.

7101 6730 4

18083 17174 5

14099 11360 6

875 376 7

*

.

. % 66 .

10000 0.4 2007 ) ( 2003-2013

100000 4 .

. ) 10000 (

%60

.

.

2005 100000

43

)2007(

-:

.

.

44

. . .

100000

10000

22 740 0.297297297 3 22 1026 0.214424951 2 75 4130 0.181598063 2 109 6203 0.175721425 2 19 1404 0.135327635 1 21 1752 0.119863014 1 8 783 0.102171137 1 17 1762 0.096481271 1 . 22 2424 0.090759076 1 16 1843 0.086814976 1 4 654 0.06116208 . 12 3514 0.034149118 . 4 1704 0.023474178 . 4 1821 0.021965953 . 3 1863 0.01610306

.

( . . )

45

-

7%

23%

25%

45%

/

. %60 %45

,

.

% 95 78%

2005 .

2005

46

050

100150200250300350400

1*

/ . 202

. 289

.

.

.

/ 188

.

47

0

2

4

6

8

10

12

14

16

.

.

.

.

.

.

) )

.

.

.

% 89 .

. .

/

%7 .. .

.

.

/

48

%4

24 42

5% .

TROPICAL

DISEASE

.

: /

.

.

35

) 25(

.

49

% 74 % 26 2005

) 1712 ( % 78

). % 59 (

) 1-0.2 ( 1.5

.

*

020406080

100120140

.

.

.

.

.

*

:

2001

50

.

.

173

2000 .

-

30 - 50

,

.

40

-

375

) (

) + ( 1.

1 643 676 1319

2. .

1 213 517 2920

3.

3 1044 1295 2334

4. .

9 414 324 1184

5. .

4 - - 676

6. .

6 96 36 176

7. .

6 30 55 85

8. .

4 48 120 168

5437

2007 ) 8(

51

1 188 2 119 3 36 4 40 5 31 6 39 7 39 8 22 9 29 10 15 11 25 12 15 13 15 14 6 15 26 16 22 17 175 842

3 100000

52

The end

54

2007-2003

0.37

0.38

0.39

0.40

0.41

0.42

0.43

0.44

2003 2004 2005 2007

100

00

without prescription(

)

% 15 .

.)2008 ( % 70 2006

.

.

.

.

(

. )

.

)10000 0.44(

. 23000

55

2007-2003

0200400600800

10001200140016001800

2003 2004 2005 2006

( . 6700 ) 4000

10000

923 6203 1.49 60 740 0.81 49 1026 0.48 191 4130 0.46 27 654 0.41 64 1752 0.37 62 1762 0.35 45 1404 0.32. 55.00 2424.00 0.23 17.00 783.00 0.22 38.00 1843.00 0.21. 40 3514 0.11 . 14 1704 0.08 . 14 1863 0.08 . 13 1821 0.07

% 72

.

56

2007

0.000.200.400.600.801.001.201.401.60

.

.

.

.

.

100

00

2007-2003

0.00

100.00

200.00

300.00

400.00

500.00

600.00

700.00

800.00

900.00

1000.00

.

.

.

.

.

-: 3

. .

. .

2005-2003

.

.

57

.

.

41

51

26

36

37

60

20

77

84

55

115 .

150 .

16 .

. 139

. 54

-

956

) ( *

**

58

2005 ( )

0.00

0.20

0.40

0.60

0.80

1.00

1.20

1.40

.

.

.

.

.

1

0000

59

.

.

. 2005

283 2005

.

) 13(

1

)(

117

2

110

3

36

4

101

60

2009 2005

.

6 1

1 2

1 3

1 4

1 . 5

*1 6

*1 7

*1 8

*1 9

10

. 625 2005 .

61

2007 . 7

. 24

% 9 , 11

459 2005 61 .

2005 ) 15(

1 2

3 4 5

6 7

8 9 10 11 12 13 14

15

16

17

62

18 19

20

21

22 23

24

)16(

63

, , ,

14 .

.

. 3

) ( ) (

. . ) (

2005 ) 17(

1 49 2 41 3 39 4 21 5 19 6 14 7 13 8 7 9 7 10 6 11 6 12 5 13 5 14 3 15 3 16 3 17 2 18 2 19 1

64

2005 ) 18(

% 18 , % 20

% 20 % 16

% ).2(

2005 ***

65

2005

66

2005

67

2005

2005

68

2005

2005

595 2005 2325 2004

. % 26

. 7.9

.

2005

2325

.Sudan medicines Index

,GIT,CVS,RT CNS, Malignant disease, Obstetrics

gynecology, urinary-tract disorders, Anti Infective , Musculoskeletal and joint

diseases & immunosuppressant ,Endocrine) .(

2002

.

2004

.

.

. on line 2006

anti infective respiratory drugs & GIT drugs &

73

. 22 % 41.9

.

% 7.9 (New Entities 86

) 2005 2004

.

.2004 ) (

.2005

GIT 170 161 94.7% 56 34.8% 105 65.2%

CVS 196 185 94.4% 62 33.5% 123 66.5%

RT 150 133 88.6% 78 58.65% 55 41.35%

CNS 247 240 97.2% 163 68% 77 32%

Anti

Infective

614

%23.8 146 %33254.1 %77.9 478

%22.1 136

Endocrine 118

97 82.2% 72 61.0% 25 21.2%

Obstetrics, 33 26 78% 22 84.6% 4 15.4%

74

*

:

gynecology , and

urinary-tract

disorders

, Malignant disease

immunosuppressant

212 202 95.28% 43 21.29% 159 78.71%

Musculoskeletal and

joint diseases

158

145 91.77% 46 31.72% 99 68.28%

Ear, Nose & Throat 119 119 100% 11 9.24% 108 90.75%

Skin 177 166 93.78% 42 25.30% 124 74.72%

Immunological

products& vaccines

Anaesthia

Miscellaneous

16 16 100% 2 12.50% 14 87.50%

75

) 21(

%

1 12

2 12

3 11

4 10

5 8

6 6

7 5

8 5

9 3

10 3

11 3

12 2

13 2

14 2

15 2

16 1

17 1

18 1

19 1

20 10

76

%71 2005 269.638.920

. 77313220 %29 . 192.325.007

.2004 % 36

. % 3 %97

: ) 22(

) 23(

) (

107 55.7%

46 23.8%

37 19.3%

2 1.2%

) ( 192 72%

SHARE %

GROUP

NO

37.6 INFECTIONS

1

9.0 CVS2

7.1 INDOCRINE SYSTEM3 6.9 OBS.GYNAECOLOGYAND UT DISORDERS 4 6.8 NUTRITION AND BLOOD5 6.5 CNS6 6.3 GIT7 5.3 MUSCULOSKELETAL DND JOINT DISEASES8 4.8 RESPIRATORY SYSTEM9 2.9 SKIN PREPRATION10 2.3 MALIGNANT DISEASE AND IMMUNOSUPPRESSION11 1.4 IMMUNOLOGICAL PRODUCTS AND VACCINES12 1.4 EYE PREPRATION13 1.1 ANEASTHESIA14 0.7 EAR.NOSE AND OROPHARYNX15

77

Co-Amoxiclav 1g Tablet.

Artemether 80mg injection .

Artesunate 100mg + (Pyrimethamin 25mg + Sulphadoxine 500mg) Tablet.

Ciprofloxacine 500mg Tablet.

Cough Syrup.

Sildenafil 50mg Tablet.

Finasetride 5 mg Tablet .

Human Insulin Mixed (30/70) Vail.

Carvidilol 25mg Tablet.

Erythromycin 250mg Tablet.

: ( STG )

Paracetamol 500mg Tablet.

Chloroquine 250mg Tablet.

Acetylsalicylic acid 300 mg Tablet.

Amoxicillin 250mg Capsule.

Sulphadoxin + Pyrimethamine (500+25) mg

Amoxicillin 500mg Capsule.

Diclofenac Sodium 25mg Tablet.

Mebendazole 100mg Tablet.

Aluminuim Hydroxide +Magnisuim Hydroxide +Semithecon Tablet

Chlorpheniramine Maleate 4mg Tablet.

78

:

. % 68 *

% 46 **

.

Chloroquine 250mg Tablet ***

) . (

.

.2004 . 26000000.... 37000000 2005

. 5000000

)24(

GROUP 27.61 Infection14.62 CVS11.11 OBS. Gynecology and UT Disorders 9.01 GIT7.19 CNS

) 25(

2005 2004

) ( ) (

%88.5 32.9 %88.8 23.7

%11.5 4.3 %11.2 3

.

79

.

. 2004 3845000 % ) 98 ( 2248002

% 41.5

.

. 104.000.000 107200000

.

.

2005

, 45708991

% 24 .

250 8

% 2-27 .

61 2005 459 % 14

.

.

2003 2005

2003 2004

2005

. 74110306

80

2005 2004 2003 ) 26(

Item

Patient Package

in 2005

Patient Package

In 2004

Patient Package

In 2003

Tablet 42,017,949 36,308,968 40167832

Capsules

11,519,595 14,397,163 12573900.5

Suspension 11,832,416 8,064,974 7219020

Syrups 3,696,651 2,978,702 904618

Topical preparation

245,528 171,137 2582660

Powders 693,989 783,103 8423493

Parental infusion 820,913 0 847099

Disinfectant (solution)

3,283,264 58,117 20000

Ampoules 0 0 1311472

Ampoules 0 0 1311472

Total 74,110,306 62,762,164 74,050,094.50

76

2005- 2003

2005 ) 27(

GIT

CVS

Respiratory System

CNS

Anti - infective

Endocrines

OBS

Blood & Nutrition

Muscle

Skin Preparation

Total

77

2005

2005 2003

Line of production

capacity 2003

Production %

Capacity 2004

Production %

Capacity 2005

Production %

Tablets 4,087,040,000 20 4222040000* 16% 4402040000*** 20 Capsules 1,170,540,000 17 1,170,540,000 20% 1,170,540,000 18 Suspensions 42,537,500 17 42,537,500 19% 42,537,500 27 Syrups 26,000,000 3 26,000,000 11% 26,000,000 14 Ampoules 10,000,000 0 10,000,000 0% 10,000,000 0 Topical preparations 7,800,000 33 7,800,000 2% 7,800,000 2 Powders 595,200 17 595,200 12% 595,200 15 Parenteral infusions 6,000,000 14 6,000,000 0% 6,000,000 14 Disinfectants(Solution) 240,000 8 960000 ** 1% 960,000 3

* - **

***

79

78%

17%0%5%

) ( .

.

(

) .

: . 1 % 17.2 %77.9

, %4.9 %5

.

80

8% 1%

88%

3%

C.V.S . 2 . %88

, .%0.6 , % 7.9

.% 3.3

. 3 %17.1 %39.2 %43.7

.%17

Salbutamol inhaler

.

81

17%0%

39%

44%

. Salbutamol tablets ,

Central Nervous System . 4

82

23%

1%

37%

39%

23%

0%

18%59%

%18 . 56.9%

,Paracetamol , Asiprin, Promethazine(

Diazepam . ( % 25

. International Controlled Medicines

. 5 Anti-infective

.

%39.2

. 39.8%

.%0.7 %22.9 .

83

41%

7%8%

44%

Endocrine System . 6 %40.8 %44.6

%6.9

Glibeclamide %7.7 . Insulin

.

. 7 %86.9

.khellin %10.5

. %2.6

84

86%

0%11%

3%

. 8 %62 .

.%38

.2005 1000000 .....%

85

62.000.00

0.00

38.00

. 9 %38.2

%43.3

. ORS folic acid .

86

44%

4%14%

38%

10% 1%17%

72%

. 10 %9.6 %16.8 %72.9

.

87

75%

0%

23%2%

. 11 %73 .

.%15

88

. 12 % .19.2 % 81.6

19.20

0.200.00

80.60

: . 13 %14 %81.2

. %3

89

14.00 0.00

4.40

81.20

. 14 ) . (

90

97.00%

3.00%

75%

0%

23%2%

% .3 % 97

. 15 %1.2 . %74.5

.

91

(

) .

. 10000000 2005

.

92

BLOOD%7

SKINPREPRATION

%15

ANTIINFECTIVE%33 MALIGNANT

DISEASE%27

CNS%13

CVS%5

93

. 5976570 % 3

%.47 ) + ( % 53) (

( ) (

( )

). ( )

2005 : )28(

Item

Disposable Syringes 1700057 197063 65993 220210 Surgical Gloves 180884 81651 - - Examination Gloves 72041 - 29500 76391 Cannula 1020341 188500 78951 1345 Condoms 66212 - 0 506597 Catheters 50173 721299 13165 478209 infusion Set 7500 506953 11917 34246 Feeding Tube 4451 - 5348 211 Blood Collection Tube 1469 - - Urine Bag 20246 758027 1488 2154 Needle 9312 - - 29892 Infusion Therapy 11931 - - Kits 22392 - - 812657 Suture Materials - - 90772 Colostomy bag - 17283 Incontinence - - - 339600 Blood bag - - - 18235 Blood giving Set - - - 10218 Anesthesia - - - 6308 Total 3167009 2472624 336937 2539922

94

) 62226607(

) 9868700(

.

.

95

%28

) (

) (

TROPICAL .

DISEASE .

.

2005 77313220.33

1550000

. 61,813,220.33

.

.

-:

.

. % 85 ,

96

) 29(

$

1

% 3 % 97

523297.8

WHO+UNFPA+ other SNAP

2

% 85 % 15

5043585.62 WHO+ Global fund+ Daffra

3

% 100 % 19

% 81

6245.71 WHO+TLM+GLRA

% 100 4

4500.00 MSF-Holland

% 100 5

246256.80 WHO + Pfizer

% 100 6

104575.50 WHO+MERCK

% 95 7 5 %water for injection

142642.72 LHL

Vaccine% 100 8

7453232 UNICEF

% 98 9 2%

2627744 UNFPA

10

16152080.15

11

Melarsoprol(1000 bottle) , Pentamidine

Isethionate (1000), Suramine sodium

(200amp)

WHO+MSF-France

97

97%

3%

/ 1

.

.

WHO UNFPA

. %3 523297.8 . -:

/ 1 .

CIPROFLOXACIN 500MG NYSTATIN 100000 IU

ANTIRETROVIRAL MEDICINES / 2

A. LAMIVIUDINE B. ZIDIVUDINE C. NELIVER D. TRI IMUNE

. %97

98

30%

1%

36%

20%

8% 5%

STREPTOMYCIN 1G INJ INH 100MG TABrifampicin 150 + inh 100 tab pyrizinamide 400 tabethambutol 400mg tab water for inj

/ 2

. %0.5

-

100000 .

2005 . 33000

.

2005 LHL

A. STREPTOMYCIN 1G + WATER FOR INJECTION B. RIFAMPICIN 300 MG + INH 150 MG C. ETHANBUTOL 400MG TAB D. PYRIZINAMIDE 400MG TAB

99

63%

16%

6%

5%1%

OPVMEASLES VACCINE WITH DILUENTBCG VACCINE WITH DILUENTDPT VACCINEHEP.B VACCINEYELLOW FEVER VACCINE

/3

(

) . % 40

. 7453332 UNICEF

100

1%3%2%

51%

25%

18%

ARTESUNATE +SP(ped)ARTESUNATE +SPARTEMETHER20 MG +LUMEFANTRINE 120MGQUININE INJSULFADOXINE /PYRIMETHAMINEQuininesulphate 300 mg tab

/4

% 50 2010

.

. % 85

. 5,043,585.62 2005

101

2.9%

3.1%2.6%

40.8%

0.1%0.8%

49.7%

MARVILON MEGISTRON INJDIS.SYRING 2ML CONDMSMICROLOUT FOLIC ACIDFERRUS SULPHATE

/5 2,627,744.00

% COMBINED CONTRACEPTIVE49

% MINI PILLS 41 .

.

102

19%

81%

/ 6 1 10000

).MDT(

. GLRA TLM

6,245.71 .

/ 7 .PRAZIQUANTIL 600MG TABLET

/ 8

. 1000

200 Melarsoprol Suramine sodium 1000

Pentamidine Isethionate

103

/ 9 .

Merck

. 1230300 . Ivermectin

/10 % 3.3

. Azithromycin

Pfizer

ITEM QTY/UNIT UNIT PRICE TOTAL PRICE AZITHROMYCIN 250 MG

TAB 46896 0.85 39861.6 AZITHROMYCIN 250 MG

SUSP 62544 3.3 206395.2

246,256.80

/ 11 6

.

. Na Stlibogluconate . 4500 30000

104

40 .

. 46

, , , .

.

. 8041585 415,332946

23 55

%80

.

.

124 2007

, .

. . ,

105

: ) 31(

57 1

18 2

0 3

3 4

* 3 5

0 6

4 7

0 8

* 3 9

5 10

0 11

0 . 12

* 4 . 13

8 . 14

16 . 15

8 . 16

* 23 17

2005 *

106

2007 2006,2005 ) 5(

2005 53 17 32%

2006 53 14 26%

2007 57 22 39%

. 2007 2005,2006 ) 6(

415,332,946.00 2005

+

107

13,392,234.15 2006

13,185,534.97 2007

.

%

( 2007,2006,2005 ) :7(

)

2007 2006 2005

MSF- HOLLAND MSF- HOLLAND MSF- FRANCE 1

-MSF MSF- FRANCE EMERGENCY 2

ITALY

ICRC CARTER 3

CENTRE

CORDAID

GOAL GOAL MSF- HOLLAND 4

-MDM MSF- BELGIUM MSF 5

SWETHERLAND

108

%) 65.6(

% 37 %). 55(

18.000

: ) 9(

,

2005 2006 2007

%60 %92 %56

%26 %4 %6

%14 %4 %38

%100 %100 %100

110

) 2006: ( )( ) 10(

2007

Praziquantel 1

Azithromycin 2

111

Ringer lactate 3

Metronidazole 4

Ciprofloxacin 5

Dexterose 6

Amoxicillin 7

Pedivit forte 8

Paracetamol 9

Mebendazole 10

) 11(

2007

MSF FRANCE 332,726.15 58%

MSF- BELGIUM 181,070.09 31%

ICRC 20,965.80 2%

MDM 11,285.33 4%

MSF- HOLLAND 11,111.40 2%

%3 17,989.95

%100 575148.72

113

-:

-:

-: .1 ( -

Artesonate ( ) 4 ( (

. ) %40 -

. ) 7/2/2005(

.

( 60 oral hypoglycemic ). %75 (CNS 237 ) 78%

114

2005

-

annual pharmaceutical statistical report -...

Documents